However, and consistent with our previous results [25], lack of Galectin-3 produced by OP9 cells significantly reduced the ability of JFK125 or JFK125R BCP-ALL cells to resist vincristine chemotherapy treatment (Figure 7a,b). Here, LGALS3 is linked to acute lymphoblastic leukemia.